Inspra

Eplerenone, the active ingredient in Inspra, is an aldosterone antagonist presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients, helping to lower blood pressure and reduce cardiac workload. By selectively blocking mineralocorticoid receptors, it prevents aldosterone‑mediated sodium retention and potassium loss, supporting cardiovascular health.

GNH USA supplies Inspra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Eplerenone, marketed as Inspra, acts on the mineralocorticoid pathway to manage cardiovascular conditions.

Hypertension: lowers blood pressure by reducing sodium and water retention. Heart failure: improves survival and reduces hospitalizations by decreasing cardiac remodeling. Left ventricular dysfunction: helps prevent progression of heart failure by mitigating aldosterone‑driven adverse cardiac changes.

Eplerenone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Hyperkalemia - Dizziness or light‑headedness - Diarrhea - Headache - Fatigue - Nausea

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia - Acute renal impairment or failure - Angioedema or severe allergic reaction - Hepatic dysfunction - Significant hypotension - Life‑threatening electrolyte disturbances

Before initiating therapy, clinicians should assess patient-specific risk factors and monitor relevant parameters.

Monitor potassium levels: regular serum potassium testing is essential to avoid hyperkalemia. Assess renal function: evaluate creatinine clearance and adjust therapy as needed. Use caution in diabetes: patients may have altered electrolyte handling. Avoid in severe hepatic impairment: liver dysfunction can increase drug exposure. Review concomitant potassium‑affecting drugs: adjust doses or consider alternatives. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Eplerenone can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone, amiloride) - ACE inhibitors or ARBs (e.g., lisinopril, losartan) - Cyclosporine or other strong CYP3A4 inhibitors

Moderate Interactions (Monitor Closely): - Digoxin (increased risk of toxicity) - Lithium (enhanced lithium levels) - Non‑steroidal anti‑inflammatory drugs (potential renal function impact)